Whitepaper: Addressing the challenges in biologics discovery with advanced flow cytometry

Biologics represent a growing class of drugs with indications in oncology, chronic inflammation, and autoimmune diseases.

However, development and production of biopharmaceuticals is expensive, time consuming, and requires a great deal of expertise.

Flow cytometry is an attractive tool for use in biopharma due to its ability to simultaneously check multiple parameters however it has few key limitations such as:

• Low Assay throughput
• Limited automated data analysis capabilities
• High sample/reagent volume requirements

In this whitepaper, discover how advanced flow cytometry can address these challenges and simplify complex workflows to deliver actionable insights.